| Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic AG Edlow, JZ Li, YC Ai-ris, C Atyeo, KE James, AA Boatin, KJ Gray, ... JAMA network open 3 (12), e2030455-e2030455, 2020 | 384 | 2020 |
| Compromised SARS-CoV-2-specific placental antibody transfer C Atyeo, KM Pullen, EA Bordt, S Fischinger, J Burke, A Michell, MD Slein, ... Cell 184 (3), 628-642. e10, 2021 | 192 | 2021 |
| AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy M Kano, AE Sosulski, LH Zhang, HD Saatcioglu, D Wang, N Nagykery, ... Proceedings of the National Academy of Sciences 114 (9), E1688-E1697, 2017 | 190 | 2017 |
| Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance K Meirelles, LA Benedict, D Dombkowski, D Pepin, FI Preffer, J Teixeira, ... Proceedings of the National Academy of Sciences 109 (7), 2358-2363, 2012 | 159 | 2012 |
| Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses EA Bordt, LL Shook, C Atyeo, KM Pullen, RM De Guzman, MC Meinsohn, ... Science translational medicine 13 (617), eabi7428, 2021 | 85 | 2021 |
| Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy S Iyer, S Zhang, S Yucel, H Horn, SG Smith, F Reinhardt, E Hoefsmit, ... Cancer Discovery 11 (2), 384-407, 2021 | 78 | 2021 |
| Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer R Qi, Y Wang, PM Bruno, H Xiao, Y Yu, T Li, S Lauffer, W Wei, Q Chen, ... Nature communications 8 (1), 2166, 2017 | 76 | 2017 |
| PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation F Sabbatino, Y Wang, X Wang, KT Flaherty, L Yu, D Pepin, S Pepe, ... Oncotarget 5 (7), 1926, 2014 | 67 | 2014 |
| Anti-Müllerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer TN Beck, VA Korobeynikov, AE Kudinov, R Georgopoulos, NR Solanki, ... Cell reports 16 (3), 657-671, 2016 | 64 | 2016 |
| AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer. D Pépin, A Sosulski, lihua Zhang, D Wang, vinod Vathipadiekal, ... Proc Natl Acad Sci U S A., 2015 | 61 | 2015 |
| CD44 splice variant v8-10 as a marker of serous ovarian cancer prognosis A Sosulski, H Horn, L Zhang, C Coletti, V Vathipadiekal, CM Castro, ... PloS one 11 (6), e0156595, 2016 | 51 | 2016 |
| The imitation switch protein SNF2L regulates steroidogenic acute regulatory protein expression during terminal differentiation of ovarian granulosa cells MA Lazzaro, D Pepin, N Pescador, BD Murphy, BC Vanderhyden, ... Molecular Endocrinology 20 (10), 2406-2417, 2006 | 51 | 2006 |
| Single-cell sequencing of neonatal uterus reveals an Misr2+ endometrial progenitor indispensable for fertility HD Saatcioglu, M Kano, H Horn, L Zhang, W Samore, N Nagykery, ... elife 8, e46349, 2019 | 41 | 2019 |
| An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance D Pepin Technology 1 (1), 2013 | 41 | 2013 |
| Single-cell sequencing reveals suppressive transcriptional programs regulated by MIS/AMH in neonatal ovaries MC Meinsohn, HD Saatcioglu, L Wei, Y Li, H Horn, M Chauvin, M Kano, ... Proceedings of the National Academy of Sciences 118 (20), e2100920118, 2021 | 40 | 2021 |
| ISWI chromatin remodeling in ovarian somatic and germ cells: revenge of the NURFs D Pépin, BC Vanderhyden, DJ Picketts, BD Murphy Trends in Endocrinology & Metabolism 18 (5), 215-224, 2007 | 39 | 2007 |
| Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-β family KN Hart, WA Stocker, NG Nagykery, KL Walton, CA Harrison, ... Proceedings of the National Academy of Sciences 118 (26), e2104809118, 2021 | 34 | 2021 |
| Tumor-derived lysophosphatidic acid blunts protective type I interferon responses in ovarian cancer CS Chae, TA Sandoval, SM Hwang, ES Park, P Giovanelli, D Awasthi, ... Cancer discovery 12 (8), 1904-1921, 2022 | 30 | 2022 |
| Müllerian-inhibiting substance/anti-Müllerian hormone as a predictor of preterm birth in polycystic ovary syndrome JY Hsu, KE James, CL Bormann, PK Donahoe, D Pépin, ME Sabatini The Journal of Clinical Endocrinology & Metabolism 103 (11), 4187-4196, 2018 | 29 | 2018 |
| Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone JMC Ferguson, D Pépin, C Duru, P Matejtschuk, PK Donahoe, CJ Burns Reproductive BioMedicine Online 37 (5), 631-640, 2018 | 29 | 2018 |
Demetrios G. VavvasSolman and Libe Friedman Professor of Ophthalmology, Director of Retina, Harvard Medical SchoolVerified email at meei.harvard.edu
